News

Attorney General Dave Sunday announced that Pennsylvania will receive over $1 million as part of a $202 million multistate ...
Results from the Phase III PURPOSE 1 (NCT04994509) and PURPOSE 2 (NCT04925752) trials highlight Yeztugo’s (lenacapavir) ...